A novel JAK1 mutant breast implant-associated anaplastic large cell lymphoma patient-derived xenograft fostering pre-clinical discoveries
… as an independent peripheral T-cell lymphoma (PTCL) entity. … in PTCL (chidamide, pralatrexate,
idelalisib, and TGR1202), … Finally, pre-clinical HTS using IL89 revealed a potential new …
idelalisib, and TGR1202), … Finally, pre-clinical HTS using IL89 revealed a potential new …
Nanomedicine as a magic bullet for combating lymphoma
… HLs shows localized spread from one lymph node to another … due to the generation of
multiple drug resistance. Repeated … T cell lymphoma with leukemic manifestations Pro-drug …
multiple drug resistance. Repeated … T cell lymphoma with leukemic manifestations Pro-drug …
MicroRNAs in Cutaneous T-cell Lymphoma Pathogenesis
R Kohnken - 2017 - rave.ohiolink.edu
… SS), the most common types of cutaneous T-cell lymphoma (CTCL), … Acquired resistance
may occur despite initial responses, and … This analysis revealed a significant inverse correlation …
may occur despite initial responses, and … This analysis revealed a significant inverse correlation …
Clinical Studies and Epi-Drugs in Various Cancer Types
TBE Cevik, Z Ozdemir, HB Erdem - Cancer Epigenetics - Springer
… useful as the next generation of diagnostic biomarkers for the … risk assessment of CML
revealed that epigenetic alterations, … or peripheral T-cell lymphoma, and phase 1/2 trials on …
revealed that epigenetic alterations, … or peripheral T-cell lymphoma, and phase 1/2 trials on …
Nanomedicines for the treatment of hematological malignancies
AK Deshantri, AV Moreira, V Ecker… - Journal of controlled …, 2018 - Elsevier
… 85% of ALL arise from the B cell lineage and 15% from T cell … This interaction can also
lead to drug resistance [39,41]. The … with a favorable prognosis of multiple types of HM [44,…
lead to drug resistance [39,41]. The … with a favorable prognosis of multiple types of HM [44,…
Impact of epigenetic modifiers on the immune system
SA Bhat, SK Sureshbabu, CS Philip… - Epigenetics of the Immune …, 2020 - Elsevier
… the roles of epigenetic modifiers not only reveals the various … IL-2 receptor marker CD25
and the T-cell activation marker … HDAC inhibitors have been shown to inhibit the generation of …
and the T-cell activation marker … HDAC inhibitors have been shown to inhibit the generation of …
[HTML][HTML] Novel therapeutics for aggressive non-Hodgkin's lymphoma
D Mahadevan, RI Fisher - Journal of clinical oncology, 2011 - ncbi.nlm.nih.gov
… types of aggressive B- and T-cell non-Hodgkin's lymphomas (… Growth factors generating
malignant stromal response that … SMIs active in PTCL include folate analog pralatrexate, 63 …
malignant stromal response that … SMIs active in PTCL include folate analog pralatrexate, 63 …
CD30 regulation by chemical and viral agents and the resulting effect on anti-CD30 therapy
ZS Hasanali - 2015 - etda.libraries.psu.edu
… There are three latency states expressing unique patterns of … in the epigenetic treatment of
T-cell prolymphocytic leukemia (T-… cytometry reveals prolymphocytes with post-thymic T-cell …
T-cell prolymphocytic leukemia (T-… cytometry reveals prolymphocytes with post-thymic T-cell …
New therapies for lymphoid neoplasms
J Zain, Y Kitagawa, M Kalac, L Paoluzzi… - The Lymphoid …, 2010 - api.taylorfrancis.com
… lymphoma revealed marked activity in patients with T cell … Pralatrexate (pdx) produces a
high and durable complete … in patients with chemotherapy resistant t-cell lymphomas. Annals of …
high and durable complete … in patients with chemotherapy resistant t-cell lymphomas. Annals of …
HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity
D Karagiannis, T Rampias - Cancers, 2021 - mdpi.com
… T-cell lymphoma (CTCL) [1], belinostat for refractory peripheral … Early structural studies in
HDAC-8 revealed the mode of … Generation of ROS was shown to happen as early as 2 hours …
HDAC-8 revealed the mode of … Generation of ROS was shown to happen as early as 2 hours …